Key result
Extended perioperative low molecular weight heparin (tinzaparin) is investigated as a strategy to improve disease-free survival following surgical resection of colon cancer.
Key points are not available for this paper at this time.
Answers are grounded in this paper and cite their sources.
Extended tinzaparin was associated with improved disease-free survival after colon cancer resection; hypothesis-generating and requires randomized confirmation before practice change.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Auer et al. (2011) studied this question. Extended perioperative low molecular weight heparin (tinzaparin) is investigated as a strategy to improve disease-free survival following surgical resection of colon cancer.
Synapse has enriched 10 related papers. Consider them for comparative context: